Research on Genetic Reversion in Primary Immunondefiriency
Research on Genetic Reversion in Primary Immunondefiriency
批准号:
18591186
负责人:
WADA Taizo
金额:
$2.53万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007
中文摘要
我们已经发现了两个新的原发免疫缺陷的遗传逆转病例,包括白细胞黏附缺陷1型(LAD-1)和X连锁严重联合免疫缺陷(XSCID)1。LAD-1是一种由ITGB2(CD18)基因突变引起的常染色体隐性遗传病,其特征是反复发生严重感染、脓液形成障碍和创面愈合缺陷。我们描述了一例严重表型LAD-1呈现体细胞嵌合体的罕见病例。患者是一个复合杂合子,携带两种不同的移码突变,这两种突变使蛋白表达消失。然而,CD18在一小部分T细胞中被检测到,但在粒细胞、单核细胞、B细胞和NK细胞中未被检测到。T细胞不是母系来源,缺乏父系突变,在体内表现出选择性优势。对分选的CD18+细胞进行的分子分析表明,它们来自携带T细胞受体VB22的单个CD84 T细胞。这些发现提示t…更多的体内自发逆转是导致我们患者的体细胞嵌合体的原因。(血液2007)2)XSCID是由细胞因子受体的共同伽马链(γc)突变引起的,通常的特征是T细胞和自然杀伤(NK)细胞的缺失以及B细胞的存在。在此,我们报告一例XSCID的非典型病例,表现为自体T和NK细胞和Omenn综合征样表现,包括红皮病、淋巴结病、肝脾肿大、嗜酸性粒细胞增多症、血清免疫球蛋白G降低、血清免疫球蛋白E升高和T细胞活化。患者携带剪接点突变(IVS1+5G>;A),导致大部分基因错误剪接,但产生少量正常剪接转录本,导致残留的γc表达和T细胞和NK细胞的发育。皮肤活检标本显示大量突变型T细胞。这些T细胞被发现具有第二位点突变,位于IVS1+5G>;A激活的隐蔽供体部位的+1位置,并导致完全恢复正确的剪接。这些发现表明,XSCID的临床谱系相当广泛,包括类似Omenn综合征的非典型病例,并强调了突变嵌合体作为可变表型表达的可能原因的重要性。(提交稿件)除了临床研究,我们还构建了表达逆转突变的逆转录病毒载体。这些载体将在未来的实验中用于评估体外诱导基因逆转的条件。较少
英文摘要
We have identified two novel cases of genetic reversion in primary immunodeficiency including leukocyte adhesion deficiency type 1 (LAD-1) and X-linked severe combined immunodeficiency (XSCID).1) LAD-1 is an autosomal recessive disorder caused by mutations in the ITGB2 (CD18) gene, and characterized by recurrent severe infections, impaired pus formation, and defective wound healing. We describe an unusual case of severe phenotypic LAD-1 presenting somatic mosaicism. The patient is a compound heterozygote bearing two different frameshift mutations which abrogate protein expression. CD 18 expression was, however, detected in a small proportion of T cells, but was undetectable in granulocytes, monocytes, B cells, and NK cells. The T cells were not of maternal origin, lacked the paternal mutation, and showed a selective advantage in vivo. Molecular analysis using sorted CD18+ cells revealed them to be derived from a single CD84 T cell carrying T-cell receptor VB22. These findings suggest t … More hat spontaneous in vivo reversion was responsible for the somatic mosaicism in our patient. (Blood 2007)2) XSCID is caused by mutations of the common gamma chain (γc) of cytokine receptors and usually characterized by the absence of T and natural killer (NK) cells and the presence of B Cells. Here, we report an atypical case of XSCID presenting with autologous T and NK cells and Omenn syndrome-like manifestations including erythroderma, lymphadenopathy, hepatosplenomegaly, eosinophilia, low serum IgG, elevated serum IgE, and the presence of activated T cells. The patient carried a splice-site mutation (IVS 1+5G>A) that caused most of the mRNA to be incorrectly spliced but produced normally spliced transcript in lesser amount, leading to residual γc expression and development of T and NK cells. The skin biopsy specimen showed massive infiltration of revertant T cells. Those T cells were found to have a second-site mutation that was located at position +1 of the cryptic donor site activated by the IVS1+5G>A, and to result in complete restoration of correct splicing. These findings suggest that the clinical spectrum of XSCID is quite broad and includes atypical cases mimicking Omenn syndrome, and highlight the importance of revertant mosaicism as a possible cause for variable phenotypic expression. (manuscript in submission)In addition to the clinical researches, we have constructed retroviral vectors expressing reversion mutations. These vectors will be used to evaluate conditions of induction of gene reversion in vitro in future experiments. Less
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1182/blood-2006-08-039057
发表时间:
2007-02-01
期刊:
BLOOD
影响因子:
20.3
作者:
[Tone, Yumi, Wada, Taizo, Yachie, Akihiro]
通讯作者:
Yachie, Akihiro
Skin infiltration of CD56^<bright> CD16^<(-)>natural killer cells in a case of X-SCID with Omenn syndrome-like manifestations
具有 Omenn 综合征样表现的 X-SCID 病例中 CD56^<bright> CD16^<(-)>自然杀伤细胞的皮肤浸润
DOI:
--
发表时间:
2007
期刊:
Eur J Haematol 79(1)
影响因子:
--
作者:
[F. Shibata, T. Toma, T. Wada, M. Inoue, Y. Tone, K. Ohta, Y. Kasahara, Sano F, Kimura M, Ikeno M, S. Koizumi, A. Yachie]
通讯作者:
A. Yachie
T細胞に遺伝子変異のreversion(復帰)を認めた白血球接着異常症の1例
T细胞基因突变逆转白细胞粘附障碍一例
DOI:
--
发表时间:
2006
期刊:
影响因子:
--
作者:
[刀祢裕美、和田泰三、柴田文恵, ら]
通讯作者:
ら
A case of leukocyte adhesion deficiency type 1 with CD 18+ T cells caused by gene reversion
基因回复所致CD 18 T细胞白细胞粘附缺陷1型1例
DOI:
--
发表时间:
2006
期刊:
影响因子:
--
作者:
[Wada, T., Tone, Y., Shibata, F., Toma, T., Kasahara, Y., Koizumi, S., Yachie, A]
通讯作者:
A
Immunophenotypic analysis of Epstein-Barr virus (EBV)-infected CD8+T cells in a patient with EBV-associated hemophagocytic lymphohisitiocytosis
EB 病毒相关噬血细胞性淋巴组织细胞增多症患者感染 Epstein-Barr 病毒 (EBV) 的 CD8 T 细胞的免疫表型分析
DOI:
--
发表时间:
2007
期刊:
European Journal of Haematology 79
影响因子:
--
作者:
[Wada T, Kurokawa T, Toma T, et. al.]
通讯作者:
et. al.
共 11 条
Characterization of inflammatory diseases with chronic excess of serum interleukin-18
-
批准号:20K08226
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.83万
-
财政年份:2020
-
负责人:WADA Taizo
-
依托单位:
Risk factors of depression among the community-dwelling elderly and a longitudinal study of intervention effects by group work
-
批准号:21590689
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2009
-
负责人:WADA Taizo
-
依托单位:
Research of clinical significance and molecular mechanisms of somatic revertant mosaicism in primary immunodeficiency.
-
批准号:20591247
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2008
-
负责人:WADA Taizo
-
依托单位:
国内基金
海外基金
登录
查看更多内容
配子生成素GGN不同位点突变损伤分子伴侣BIP及HSP90B1功能导致精子形成障碍的发病机理
-
批准号:82371616
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姚晨成
-
依托单位:
Pik3r2基因突变在家族内侧颞叶癫痫中的作用及发病机制研究
-
批准号:82371454
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:郝勇
-
依托单位:
GREB1突变介导雌激素受体信号通路导致深部浸润型子宫内膜异位症的分子遗传机制研究
-
批准号:82371652
-
项目类别:面上项目
-
资助金额:45.00万元
-
批准年份:2023
-
负责人:刘开江
-
依托单位:
22q11.2染色体微重复影响TOP3B表达并导致腭裂发生的机制研究
-
批准号:82370906
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:代杰文
-
依托单位:
RET基因634位点不同氨基酸改变对甲状腺C细胞的影响与机制研究
-
批准号:82370790
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:叶蕾
-
依托单位:
KMT2A基因突变通过DNMT3靶向调控GBP2导致神经发育障碍的机制研究
-
批准号:82371867
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:王剑
-
依托单位:
Consequences of MALT1 mutation for B cell tolerance
-
批准号:32100719
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:James Qun Wang
-
依托单位:
自噬基因Epg5在诺如病毒感染过程中的作用
-
批准号:32070745
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:路群
-
依托单位:
C9ORF72-SMCR8复合物在小胶质细胞中的功能及其介导的炎症反应
-
批准号:32070743
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:杨玫
-
依托单位:
错义突变介导的TGR5持续活化与功能丧失在胆管纤维化与结石形成中的作用及机制研究
-
批准号:81960125
-
项目类别:地区科学基金项目
-
资助金额:30.0万元
-
批准年份:2019
-
负责人:赵礼金
-
依托单位: